Reframing the impact of combined heart-liver allocation on liver transplant wait-list candidates

Liver Transplantation

Volumn 20, Issue 11, 2014, Pages 1356-1364

  Goldberg, David S ^a,b   Reese, Peter P ^a,b   Amaral, Sandra ^b,c   Abt, Peter L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; CONTROLLED STUDY; DETERIORATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE POLICY; HEART LIVER TRANSPLANTATION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; UNITED STATES; COHORT ANALYSIS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION;

ADULT; ALLOGRAFTS; COHORT STUDIES; FEMALE; HEART TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84914695608     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23957     Document Type: Article

References (22)

1. Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology 2012;56:1160-1169.
2. Colvin-Adams M, Valapour M, Hertz M, Heubner B, Paulson K, Dhungel V, et al. Lung and heart allocation in the United States. Am J Transplant 2012;12:3213-3234.
3. Ruebner R, Goldberg D, Abt PL, Bahirwani R, Levine M, Sawinski D, et al. Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant 2012;12:2958-2965.
4. Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM. Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol 2013;8:1135-1142.
5. Sharma P, Schaubel DE, Guidinger MK, Goodrich NP, Ojo AO, Merion RM. Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant 2011;11:2372-2378.
6. Wolf JH, Sulewski ME, Cassuto JR, Levine MH, Naji A, Olthoff KM, et al. Simultaneous thoracic and abdominal transplantation: can we justify two organs for one recipient? Am J Transplant 2013;13:1806-1816.
7. Yi SG, Burroughs SG, Loebe M, Scheinin S, Seethamraju H, Jyothula S, et al. Combined lung and liver transplantation: analysis of a single-center experience. Liver Transpl 2014;20:46-53.
8. United Network for Organ Sharing. Policy 5.8: organ allocation to multiple organ transplant recipients. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN-Policies.pdf#nameddest5Policy-09. Accessed October 2013.
9. Yeh H, Smoot E, Schoenfeld DA, Markmann JF. Geographic inequity in access to livers for transplantation. Transplantation 2011;91:479-486.
10. Reese PP, Veatch RM, Abt PL, Amaral S. Revisiting multiorgan transplantation in the setting of scarcity. Am J Transplant 2014;14:21-26.
11. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008;8:2243-2251.
12. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait list. Gastroenterology 2012;143:1261-1265.
13. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
14. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010;10:1643-1648.
15. Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in wait-list mortality rates with increased Model for End-Stage Liver Disease scores for candidates with hepatocellular carcinoma vs candidates without hepatocellular carcinoma. Liver Transpl 2012;18:434-443.
16. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 26 2008;300:2371-2378.
17. French B, Heagerty PJ. Analysis of longitudinal data to evaluate a policy change. Stat Med 2008;27:5005-5025.
18. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
19. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006;43:345-351.
20. Bittermann T, Niu B, Hoteit MA, Goldberg D. Waitlist priority for hepatocellular carcinoma beyond Milan criteria: a potentially appropriate decision without a structured approach. Am J Transplant 2014;14:79-87.
21. Rawls J. A theory of justice. Cambridge: Belknap Press, 1971.
22. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010;10:1003-1019.